Bakgrund. Barns smärta kan orsaka oro och ångest, vilket även kan öka föräldrars stressnivå och förtroende för hälso- och sjukvård. Inom slutenvård visar forskning att mindre än en tredjedel barn fått adekvat smärtlindring. Smärtlindring inom barnhälsovård är värdefull kunskap, med tanke på det stora antal barn som vaccineras via Sveriges vaccinationsprogram. Syftet med litteraturstudien var att beskriva effekter av bröstmjölk och glukoslösning som smärtlindringsmetoder vid procedurrelaterad smärta hos barn 1–24 månader, enligt den vetenskapliga litteraturen. Metod. Designen var deskriptiv med kvantitativ ansats och gjordes i form av en litteraturstudie. Studiens resultat grundades på 18 kvantitativa artiklar från databaserna PubMed och Cinahl.  Huvudresultat. I de 18 studier som ingick i resultatet undersökte sex effekt av bröstmjölk, vilka alla hade signifikant effekt mot procedurrelaterad smärta. Detta oberoende av administrering. Av de tio artiklar som undersökt effekten av glukoslösning visade tre studier signifikant effekt mot procedurrelaterad smärta. I de två studier som studerat glukoslösning och bröstmjölk, visade en att bröstmjölk hade signifikant bättre smärtstillande effekt än glukoslösning. I den andra studien jämfördes inte interventionsgrupperna, utan huruvida effekten var jämlik, vilket den visade sig vara. Slutsats. Resultatet visar att bröstmjölk som smärtlindringsmetod för barn 1–24 månader inför smärtsamma procedurer, var effektiv och enkel och kan motverka vårdlidande. Glukoslösning visade varierande effekt som smärtlindringsmetod. I studien som jämfört de två, var bröstmjölk mer effektiv. Vidare forskning, med fler studier kan bättre säkerställa vad som är mest optimalt / Background. Children's pain, in connection with care procedures, is contrary to several legal regulations and guidelines for the professional practice of district nurses. Children's pain can cause worry and anxiety and can also increase parents' stress level and trust in health care. Inpatient care-research shows that less than a third of children receive adequate pain relief. Pain relief in child health care is valuable knowledge, given the large number of children who are vaccinated via Sweden's vaccination program. The purpose of the literature study was to describe the effects of breast milk and glucose solution as pain relief methods for procedure-related pain in children 1–24 months, according to the scientific literature. Method. The design was descriptive with a quantitative approach and was done in the form of a literature study. The study's results were based on 18 quantitative articles from the databases PubMed and Cinahl. Main results. In the 18 studies included in the results, six investigated the effect of breast milk, which all had a significant effect on procedure-related pain, independent of administration. Of the ten articles investigating glucose solution, three showed a significant effect against procedure-related pain. In the two studies that studied glucose solution and breast milk, one showed that breast milk had a significantly better pain-relieving effect than glucose solution.  Conclusion. The results show that, as a pain relief method for children 1–24 months before painful procedures, breast milk was effective, simple and can counteract care suffering. Glucose solution showed variable efficacy as a pain relief method. In the study comparing the two, breast milk was more effective. Further research, with more studies can better ensure what’s most optimal.

Bakgrund: Smärta är ett subjektivt fenomen som kan definieras som en personlig sensoriskt eller emotionellt obehaglig upplevelse relaterad till faktisk eller potentiell skada, där biologiska, psykologiska och sociala faktorer har betydelse. Långvarig smärta definieras som smärta vilken har pågått eller varit återkommande under mer än tre månader. Smärta kan påverka kroppens system och funktioner, såsom sömn, sinnesstämning och kognitiv funktion. En biopsykosocial förklaringsmodell, vilken tillstår smärtproblematiks flerdimensionalitet, är idag vedertagen för att beskriva, bedöma och behandla smärta. Långvarig smärta är en vanligt förekommande diagnos i både industrialiserade och utvecklingsländer. Behandling vid långvarig smärta innefattar farmakologisk behandling men även icke-farmakologiska alternativ, exempelvis psykoterapeutisk behandling, akupunktur eller fysisk aktivitet. Syfte: Syftet var att belysa patienters erfarenheter av icke-farmakologisk smärtbehandling vid långvarig smärta. Metod: Litteraturstudien var av kvalitativ, induktiv ansats och baserades på tio kvalitativa artiklar. Datan bearbetades genom en kvalitativ innehållsanalys. Resultat: Fyra huvudkategorier framkom av analysen; Fysiska erfarenheter, Inverkan på känsloliv och inre förmågor, Resurser och strategier för smärthantering och Inverkande faktorer på användande och effekt. Vanligt förekommande erfarenheter av icke-farmakologisk smärtbehandling, både vid fysikaliska och psykologiska behandlingsmetoder, innefattade förändrade upplevelser av välmående och livskvalitet, samt ökad kunskap och förståelse. Konklusion: Flertalet icke-farmakologiska smärtbehandlingsmetoder gav smärtlindring. Deltagare lade dock genomgående tyngd vid andra erfarenheter relaterade till exempelvis livskvalitet, avslappning, kunskap kring smärttillstånd, relation till vårdgivare samt tillgång till resurser och strategier för smärthantering. Genom förståelse för patienters erfarenheter, kunskap kring långvarig smärta och behandlingsalternativ samt förmåga till relationsbyggande kan sjuksköterskan skapa en förbättrad personcentrerad omvårdnad och bidra till minskat lidande hos patienter med långvarig smärta. / Background: Pain is a subjective phenomenon which can be defined as a personal sensory or emotional experience associated with actual or potential tissue damage, influenced by biological, psychological and social factors. Chronic pain is defined as pain persisting or recurring for three months or longer. Pain can influence the body’s functions, such as sleep, frame of mind and cognitive function. A biopsychosocial explanatory model, which acknowledges pain’s multidimensionality, is an established way of describing, assessing and treating pain. Chronic pain is common in both developed and developing countries. Treatment includes pharmacological therapy as well as non-pharmacological options, for example psychotherapy, acupuncture or exercise movement techniques. Aim: The aim of the study was to illustrate chronic pain patients’ experiences of non-pharmacological pain management. Method: The literature study was done with a qualitative, inductive approach on the basis of ten qualitative articles. A qualitative content analysis was performed to process the data. Result: Four categories were found through the data analysis; Physical experiences, Impact on emotions and inner capabilities, Resources and strategies for pain management and Factors influencing use and effect. Common experiences of non-pharmacological pain management, both physical and psychological treatments, included changed perceptions of well-being and quality of life, as well as increased knowledge and understanding. Conclusion: Multiple non-pharmacological pain management methods gave pain relief. Participants put an emphasis on other experiences related to for example quality of life, relaxation, knowledge of pain mechanisms, caregiver relationships and access to pain management resources and strategies. Through understanding patients’experiences, having knowledge of chronic pain conditions and treatment options and relationship building skills nurses can provide a more person-centered care and can contribute to decreased suffering in patients with chronic pain.

No description available.

Yes / The acute hospital is a challenging place for a person with dementia. Behavioural and psychological symptoms of dementia (BPSD) are common and may be exacerbated by the hospital environment. Concerns have been raised about how BPSD are managed in this setting and about over reliance on neuroleptic medication. This study aimed to investigate how BPSD are managed in UK acute hospitals. Method(s): A longitudinal cohort of 230 patients with dementia admitted to two acute NHS hospitals. BPSD were measured every four days (Behave-AD scale), as well as documentation of pharmacological prescriptions and non-pharmacological management. Results: The overall prevalence of BPSD was 75%, with aggression and activity disturbance being the most common. Antipsychotics were prescribed for 28 (12%) patients; 70% of these prescriptions were new on admission. Benzodiazepines were prescribed for 27 (12%) patients, antidepressants were prescribed for 37 (16%) patients, and sedatives were prescribed for 14 (3%) patients. Patients who were prescribed antipsychotics, after adjusting for end of life medication, age and dementia severity, were significantly more likely to die (adjusted hazard ratio 5.78, 95% CI 1.57, 21.26, p= 0.008). Nonpharmacological management was used in 55% of participants, most commonly psychosocial interventions (36%) with little evidence of monitoring their effectiveness. A form of restraint was used during 50 (22%) patients’ admissions. Conclusions: Antipsychotic medications and psychosocial interventions were the main methods used to manage BPSD; however, these were not implemented or monitored in a systematic fashion. / Alzheimer's Society; BUPA Foundation

Summaries in Afrikaans and English / Text in Afrikaans / Tourettesindroom is 'n lewenslange versteuring wat gekenmerk word deur motoriese en vokale trekkings saam met moontlik ook komorbiede simptome soos aandagtekort-hiperaktiwiteitsversteuring, obsessief-kompulsiewe versteuring, aggressie en depressie. Die sindroom kom in hoe mate in Suid-Afrika voor en die pastor kan dus heel moontlik daarmee te doen kry. Die beste behandeling vir die sindroom is medikasie saam met gedrags- en gesinsterapie toegedien deur 'n multidissiplinere span. Die pastor het 'n rol om te vervul in hierdie span probleme het aangesien persone met Tourettesindroom dikwels in hulle verhoudings met God, hulleself en ander mense. Vir effektiewe pastorale berading aan sodanige persone, moet die pastor deeglike kennis he van die sindroom en die simptome daarvan, asook van sy of haar invalshoek as pastor. 'n Moontlike kernmoment van die sindroom wat deur die pastor aangespreek kan word, is die verlies aan beheer wat deur dje lyer ervaar word. Die sindroom kan as 'n verskoning gedrag en gebruik word vir negatiewe en onverantwoordelike die pastor sal die lyer dus moontlik eties moet konfronteer op 'n medemenslike wyse. / Tourette Syndrome is a lifelong disorder. Symptoms are motoric and vocalic tics with possible comorbid symptoms such as attention deficit disorder with hyperactivity, obsessive-compulsive disorder, and depression. It is frequent among South Africans and the pastor will probably be confronted with persons struggling with the syndrome. The best therapy for Tourette Syndrome is medication in conjunction with behaviour and family therapy administered by a multi-disciplinary team. Persons with Tourette Syndrome have problems maintaining relationships with God, themselves and others. The pastor therefore has a definite role to play in the team. Knowledge of the syndrome and its symptoms, and of pastoral care are essential for succesful pastoral counseling. A possible central theme of the syndrome is the loss of control experienced by the person with the syndrome. The syndrome can become an excuse for negative and irresponsible behaviour and ethical confrontation may be necessary. / Philosophy, Practical & Systematic Theology / M. Th. (Praktiese Teologie)

Dissertation submitted in partial compliance with the requirements for a Masters Degree in Tehcnology: Chiropractic, Durban University of Technology, 2009. / Background: The aim of this study was to determine the knowledge, perception and utilisation of vitamins and minerals, natural medicines and pharmacological agents as adjuncts to Chiropractic practice in South Africa. Method: This study was a population based cross sectional survey utilising a descriptive, quantitative questionnaire study design. The questionnaire was distributed to all practicing qualified Chiropractors (n=388) and masters Chiropractic students (n=102) in South Africa. Results: The results obtained (30.4% response rate), indicated that the majority of the respondents (62.8%) felt qualified to advise patients on vitamins and mineral supplements and had a positive view of the use of vitamins and minerals as part of Chiropractic patient management (86.6%). The majority of the practitioners were aware that topical substances are part of the scope of practice and males were nearly twice as likely as females to use them. The majority thought biopuncture should be available to Chiropractors (82%) and felt that Chiropractors should challenge the legislation to incorporate biopuncture as part of the scope of practice (77.5%). Most respondents agreed with the statement indicating that NSAIDS should be part of Chiropractic scope of practice and 71% of respondents felt that being able to use NSAIDS in non-emergency situations would enhance patient retention. This study revealed that amongst the student population the majority, if allowed, would consider administering pharmacological agents in practice (55.1%). Conclusion: A correlation exists between the perception, knowledge and utilisation of vitamins and minerals, natural medicines and pharmacological agents in the Chiropractic profession with respect to the demographic data and there is a significant difference in opinion between qualified Chiropractors and Chiropractic masters students regarding perception, knowledge and utilisation of these adjuncts to practice.

Thesis (MSc)--Stellenbosch University, 2014. / ENGLISH ABSTRACT: Context: Cardiovascular diseases are the leading cause of death globally. Myocardial infarction is responsible for the highest number of deaths due to cardiovascular disease. Objective: We have previously shown that acute benfotiamine administration at the onset of reperfusion is associated with decreased infarct size and preserved contractile function in response to ischemia-reperfusion. We aimed to evaluate the involvement of the phosphatidylinositol 3-kinase/Akt (PI3K/Akt) and Janus kinase/signal transducer and activator of transcription (JAK/STAT) pro-survival signaling pathways in mediating these cardioprotective effects. Materials and Methods: Part One - Hearts were rapidly excised from Wistar rats and mounted on a Langendorff perfusion apparatus. After stabilization, hearts were subjected to 30 minutes of regional ischemia and 120 minutes of reperfusion. The control group received no treatment. Experimental groups were treated with 100 μM benfotiamine ± 0.1 μM Tyrphostin AG490 or Wortmannin (inhibitors of JAK2 and PI3K, respectively), dissolved in dimethyl sulfoxide. The vehicle control group received an equivalent dose of dimethyl sulfoxide. All treatments were administered for 20 minutes at the onset of reperfusion. Functional parameters were measured throughout, to test the effects of benfotiamine ± pro-survival pathway inhibitors on functional recovery. In addition, hearts were stained with Evans blue and triphenyltetrazolium chloride to assess the effects of benfotiamine ± pro-survival pathway inhibitors on infarct size. Part Two - Hearts that were perfused ± 30 minutes of global ischemia and ± 20 minutes of benfotiamine administration, were used to assess PI3K/Akt and JAK/STAT signaling in response to ischemia-reperfusion and benfotiamine treatment. As with previous experiments, benfotiamine was administered at a concentration of 100 μM, at the onset of reperfusion. Tissues were assessed by Western blot analysis. Results: 20 minutes of acute benfotiamine administration at the onset of reperfusion led to a decrease in infarct size (35.6 ± 2.4% vs. 55.7 ± 5.0% [p<0.05]). Inhibition of PI3K/Akt signaling by addition of Wortmannin abrogated this infarct-limiting effect (51.5 ± 1.3% vs. 35.6 ± 2.4% [p<0.05]). However, inhibition of JAK/STAT signaling had no effect. There were no significant differences in left ventricular developed pressure, coronary flow rate or heart rate during the experiments. In addition, 20 minutes of acute benfotiamine administration at the onset of reperfusion lead to an increase in phospho-FOXO/FOXO in the cytosolic fraction, but no significant change in phospho-STAT3/STAT3 in the nucleus. Conclusions: Our results suggest that acute benfotiamine administration at the onset of reperfusion may act to reduce infarct size via activation of PI3K/Akt pro-survival signaling. / AFRIKAANSE OPSOMMING: Konteks: Kardiovaskulêre siekte is die hoofoorsaak van sterftes wêreldwyd. Miokardiale infarksie is verantwoordelik vir die grootste aantal sterftes weens kardiovaskulêre siekte. Doel: Ons het voorheen getoon dat akute benfotiamientoediening met die aanvang van reperfusie geassosieer is met „n verkleining in die infarkgrootte, en dit het verder ook die kontraktiele funksie in reaksie op ischemie-reperfusie behou. Ons doel was om die betrokkenheid van die fosfatidielinositol 3-kinase/Akt (PI3K/Akt) en Janus kinase/seintransduseerde en aktiveerder van transkripsie (JAK/STAT) pro-oorlewings seinweg in die mediasie van hierdie kardiobeskermende effekte te evalueer. Materiale en Metodes: Deel een - Harte is vinnig vanuit Wistarrotte verwyder en op die Langendorff-perfusieapparaat gemonteer. Na stabilisering is die harte blootsgestel aan 30 minute regionale ischemie en 120 minute reperfusie. Die kontrole groep het geen behandeling ontvang nie. Eksperimentele groepe is met 100 μM benfotiamien ± 0.1 μM Tirfostien AG490 of Wortmannin (inhibeerders van JAK2 en PI3K, onderskeidelik) behandel, opgelos in dimetielsulfoksied. Die draer-kontrole groep het „n ekwivalente dosis van dimetielsulfoksied ontvang. Alle behandelings is toegedien vir 20 minute aan die begin van die reperfusie. Funksionele parameters is deurgaans gemeet om te toets vir die effekte van benfotiamien ± pro-oorlewingsweg inhibeerders op funksionele herstel. Verder is die harte met Evans-blou en trifenieltetrazoliumchloried gekleur om die effek van benfotiamien ± pro-oorlewingsweg inhibeerders op die infarkgrootte te bepaal. Deel twee - Harte is vir ± 30 minute perfuseer met globale ischemie en ± 20 minute met benfotiamientoediening. Dit was gebruik om PI3K/Akt en JAK/STAT seine as gevolg van ischemie-reperfusie en benfotiamienbehandeling te ondersoek. Soos met die vorige eksperimente, is benfotiamien toegedien by ‟n konsentrasie van 100 μM met die aanvang van reperfusie. Weefsel is ondersoek deur middel van Western blot analise. Resultate: 20 minute van akute benfotiamientoediening, met die aanvang van reperfusie, het tot „n verkleining in die infarkgrootte (35.6 ± 2.4% vs. 55.7 ± 5.0% [p<0.05]) gelei. Inhibering van die PI3K/Akt seinweg deur toediening van Wortmannin het die infark-beperkende effek opgehef (51.5 ± 1.3% vs. 35.6 ± 2.4% [p<0.05]). Inhibering van JAK/STAT seine het egter geen effek getoon nie. Daar was geen beduidende verskille in linkerventrikulêr-ontwikkelde druk, koronêre-vloeitempo of harttempo tydens die eksperimente nie. Verder, 20 minute van akute benfotiamientoediening met die aanvang van reperfusie het „n toename in fosfo-FOXO/FOXO in die sitosoliese-fraksie veroorsaak, maar geen beduidende verandering in fosfo-STAT3/STAT3 is in die nukleus waargeneem nie. Gevolgtrekkings: Ons resultate suggereer dat akute benfotiamientoediening met die aanvang van reperfusie moontlik die infarkgrootte via aktivering van die PI3K/Akt pro-oorlewingsein kan verklein.

Objectives. To investigate diabetes prevalence, incidence, mortality trends, the effects of hyperglycaemia and blood pressure, diabetes and hypertension treatment, and the effect of screening detection on total and cardiovascular disease (CVD), myocardial infarction (MI) and stroke incidence. Study population and methods. Between 1972 and 2001 all patients with diabetes, some detected clinically and some by case-finding procedures (screening), were entered in a diabetes register at Laxå Primary Health Care Center in Sweden. The register included information on medical treatment and laboratory data as well as information on mortality and morbidity from National Registers. The register was supplemented with five non-diabetic subjects, matched to each diabetes patients by age, sex, and year of detection. Results. During the study period 776 new diabetes cases was found, 36 type 1 diabetes mellitus and 740 type 2 diabetes mellitus. Age standardised incidence and prevalence rates for type 1 and type 2 diabetes did not increase over time. Diabetic patients had 17% higher mortality rate than non-diabetic persons, 22% in women and 13% in men. The corresponding over-mortality in CVD was 33%, 41% in women and 27% in men. CVD mortality decreased across time in non-diabetic subjects and in diabetic men but not in diabetic women. Results regarding coronary heart disease (CHD) were similar. CVD incidence increased with fasting blood glucose (FBG), body mass index (BMI), mean arterial blood pressure (MABP), and decreased with metformin treatment and sulfonylurea. Myocardial infarction incidence increased with FBG, BMI and MABP, and decreased with metformin treatment. Stroke incidence increased with MABP. There was no difference in prognoses between those detected by screening or clinically. Conclusions. Diabetes prevalence and incidence did not change over time. The over-mortality according to diabetes was moderate. CVD and MI during follow up were negatively affected by hypertension and hyperglycaemia, and positively by pharmacological diabetic treatment. For stroke no pharmacological protective effect was seen. Screening did not improve prognosis.

Background Rheumatoid arthritis (RA) is a systemic progressive destructive joint disease with an increased risk for co-morbidity and premature death if untreated. Cardiovascular disease (CVD) is the main cause of death but also other co-morbid conditions contribute to the patient’s shorter life expectancy. Inflammation is important for the development of CVD, but knowledge of its relationship with other co-morbidities is sparse. Early disease modifying anti rheumatic drugs (DMARDs) can suppress disease activity and improve the long-term outcome. The aim of this thesis was to evaluate prospectively aspects of disease activity and severity in a large cohort of patients with early RA. Predictive and prognostic markers, e.g., antibodies against citrullinated proteins/peptides (ACPAs), occurring in early disease and with implications for disease outcome and co-morbidity were evaluated. Methods Patients with early RA (i.e., symptomatic for ≤12 months) have, since December 1995, been consecutively included in a large survey of prospective and observational studies on the progression of RA and the development of co-omorbidity. Autoantibodies, inflammatory, genetic markers and radiographs have been analyzed. In paper I, 210 RA patients and 102 controls were followed regularly for two years. The predictive value of four different ACPAs in relation to disease activity and radiological progression was evaluated. In Paper II (n = 700) and in Papers III-IV (n =950), patients with early RA from the four northern-most counties of Sweden were followed regularly for 5 years. Data on risk factors and co-morbidity was collected, according to the study protocol, from clinical records and self-reported questionnaires from patients at inclusion into the study cohort and after five years. The predictive value of traditional and potential disease related risk factors for new cardiovascular events (CVE) was evaluated (II). In Paper III, the impact of age at the onset RA, stratified as being young onset RA (&lt;58 years; YORA) and late onset RA (≥58 years; LORA) on disease activity, severity and chosen treatment, was evaluated. In Paper IV, the development of new co-morbidities after RA onset and their relation to inflammatory activity was assessed. Results The presence of anti-mutated citrullinated vimentin (MCV ) antibodies was associated with a more severe disease course, estimated by disease activity score, erythrocyte sedimentation rate (ESR) and swollen joint count after 24 months, compared with anti-CCP2, anti-CCP3, and anti CCP3.1 antibodies. In Paper II, the incidence of a new CVE during 5 years was explained by several of the traditional CV risk factors, and potentiated by a high disease activity. Treatment with DMARDs decreased the risk. In Paper III, LORA patients were associated with greater disease activity/severity at disease onset and over time compared with YORA who were more often ACPA positive. YORA patients were treated earlier with DMARDs, whilst LORA patients were more often treated with corticosteroids and less so with DMARDs early in the course of their disease. In Paper IV, 53%of patients already had one or more co-morbidities already at the onset of RA. After 5 years, 41% of the patients had developed at least one new co-morbidity. ESR at baseline and accumulated disease activity were associated with a new co-morbidity after five years. Conclusion Early RA patients sero-positive for anti- MCV antibodies appeared to have a higher disease activity over time. The occurrence of a new CVE in early RA patients was predicted by traditional risk factors for CVD which were potentiated by a high disease activity. Treatment with DMARDs decreased the risk. Patients with young onset of RA were associated with a higher frequency of ACPA. Late onset of RA was associated with higher disease activity/severity at inclusion and over time. However, LORA patients were more often treated with corticosteroids and less so with DMARDs early in the disease course. Development of a new co-morbidity during the five years following diagnosis was related to ESR.

O presente estudo teve por objetivo avaliar a eficácia de uma intervenção não-farmacológica de distração no alívio de dor aguda em crianças hospitalizadas submetidas a procedimentos dolorosos por demanda clínica, controlando variáveis de estresse e catastrofização de dor. O delineamento do estudo foi um ensaio clínico randomizado cruzado (cross-over). A amostra do estudo foi composta por 40 crianças na fase escolar (6 a 11 anos), que estavam internadas na Enfermaria de Pediatria do Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto-USP e que foram submetidas a procedimento de punção venosa ou arterial prescrito por demanda clínica. Os participantes foram randomizados em dois grupos, sendo que todas as crianças receberam a intervenção e foram controles de si mesmas, mas em dois períodos distintos. O estudo foi aprovado pelo Comitê de Ética em Pesquisa do hospital. Inicialmente, avaliações do estresse e catastrofização de dor foram processadas, utilizando-se, respectivamente, a Escala de Estresse Infantil (ESI) e a Escala de Catastrofização de Dor para Crianças (PCS-C), a fim de controlar essas variáveis. Para avaliação da intensidade de dor foram utilizados os seguintes instrumentos: Escala Visual Analógica (VAS) e Escala de Faces Revisada (FPS-R). Na coleta de dados, o Grupo 1 recebeu a intervenção de distração audiovisual antes e durante um procedimento de punção realizado pela enfermeira e, em outro dia um segundo procedimento de punção foi realizado sem intervenção. No Grupo 2, por sua vez, o procedimento ocorreu de forma inversa, sendo primeiramente sem intervenção e posteriormente com intervenção. A intervenção constituiu-se na distração audiovisual com o direcionamento da atenção da criança antes e durante o procedimento doloroso para filmes de curta metragem com temáticas infantis. Após a conclusão dos procedimentos de punção eram aplicadas as duas escalas de dor para avaliar a percepção da intensidade de dor pelas crianças. A análise de variância ANOVA 2 X 2 com comparação entre- e intra-grupos foi processada com a finalidade de atender ao objetivo do estudo. O nível de significância adotado em todas as análises realizadas no presente estudo foi de 5%. Os resultados mostraram que os dois grupos foram semelhantes nas medidas basais de estresse e catastrofização de dor; não houve diferenças estatisticamente significativas nessas variáveis. Verificou-se que houve diferença estatisticamente significativa entre os grupos nos períodos com e sem intervenção da distração; os escores em ambas as escalas FPS-R e VAS mostraram-se menores no período com distração em comparação ao período sem intervenção. Além disso, a sequência de exposição da distração nos grupos e o período em que foi realizada a distração também interferiram significativamente no efeito da intervenção de distração. A análise do efeito carry-over mostrou que aproximadamente 30% dos efeitos estimados no alívio de dor foram atribuídos exclusivamente à intervenção de distração. Em conclusão, a intervenção de distração audiovisual foi eficaz na redução da percepção da intensidade de dor durante o procedimento doloroso agudo em crianças hospitalizadas. A técnica de distração pode ser recomendada como uma estratégia não-farmacológica simples e eficaz para alívio da dor aguda, podendo ser implementada na prática clínica em ambientes de cuidados pediátricos. / The present study was aimed to evaluate the efficacy of a non-pharmacological intervention of distraction for acute pain relief in hospitalized children undergoing painful procedures by clinical demand, controlling variables of stress and pain catastrophizing. The study design was a crossover randomized controlled trial. The sample was composed of 40 children at school age (6-11 years), who was admitted in the pediatric ward of the Hospital of Clinics of Ribeirão Preto Medical School-USP and who underwent venipuncture or arterial puncture prescribed by clinical demand. Participants were randomized into two groups and all children that received the intervention were themselves controls, in two different periods. The study was approved by the Committee of Ethics on Research of the Hospital. Initially, the stress and pain catastrophizing assessments were performed using The Child Stress Scale (CSS) and Pain Catastrophizing Scale for Children (PCS-C), respectively, aiming to control these variables. The instuments used for pain assessment were the following: The Visual Analog Scale (VAS) and The Faces Pain Scale Revised (FPS-R). In the data collection, the Group 1 received the audiovisual distraction intervention before and during the puncture performed by the nurse and in another day a second puncture was performed without intervention. Contrarily, in Group 2 the procedure was first without intervention and subsequently with intervention in another day. The intervention consisted in audiovisual distraction by focusing the child\'s attention before and during the painful procedure to short films about infant thematics. The two pain scales were applied after the puncture procedures to assess the childrens perception of pain intensity. An ANOVA 2 X 2 analyses of variance was performed including between- and within-groups comparisons. The level of significance adopted in all analyzes of the present study was 5%. The results showed that the two groups were similar in the baseline of stress and pain catastrophizing outcomes; there were no significant differences between the groups in these variables. There was a statistically significant difference between groups in the periods with and without distraction intervention; the scores in both scales FPS-R and VAS were lower during distraction compared with the no intervention period. Furthermore, the sequence of exposure of the distraction in the groups and the period that distraction was performed also significantly interfered in the effect of distraction intervention. The analysis of the carry-over effect showed that around 30% of the estimated effects on pain reliefing were attributed to the distraction intervention. In conclusion, the intervention of audiovisual distraction was efficacy in reducing the perception of pain intensity during routine acute painful procedure in hospitalized children. The findings of the present study endorse that distraction is a simple and efficacious non-pharmacological management for acute pain relief, which could be implemented in clinical practice of pediatric care settings.